Novartis on Thursday posted a slightly more optimistic full-year earnings forecast, citing the strong growth of drugs such as ...

AbbVie partners with IGI Therapeutics for ISB 2001, a potential cancer and autoimmune therapy. Read more here.

AbbVie ABBV has been expanding its oncology portfolio over the past few years. While the company was originally focused on two blood-cancer drugs — Imbruvica and Venclexta — it has since built a ...

Everything to Know about Macro and Markets Stock indexes fell on Friday, reversing mid‑week gains and closing in the red, as the tariff theme came ...

President Trump is amping up trade threats, again unveiling a new batch of letters to country leaders outlining tariffs on ...